Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New combo aims to extend life in tough lung cancer
Disease control Recruiting nowThis phase II trial tests whether combining the chemotherapy drug temozolomide with the immunotherapy atezolizumab can shrink tumors or prolong survival in people with advanced small cell lung cancer that has spread or returned. About 56 participants who have already had one or t…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental combo targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis early-phase trial is testing whether combining two drugs—vismodegib and atezolizumab—is safe and tolerable for people with advanced non-small cell lung cancer that has returned or spread. Vismodegib blocks certain enzymes that help cancer cells grow, while atezolizumab helps…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for advanced lung cancer: drug combo trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug (PBF-1129) combined with an immunotherapy (nivolumab) in 30 adults with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand side effects. Participants must have already tr…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC